About ETIOME INC.
Etiome is a pioneering company focused on developing Biostaged Medicines to preemptively treat diseases before they become debilitating. The company uses single-cell omics and AI to identify disease-modifying targets and improve long-term health outcomes.
Development of Biostaged Medicines for stage-specific therapeutic interventionUse of single-cell omics and artificial intelligence for disease modelingIdentification of disease-modifying targets through molecular and cellular analysisCreation of predictive models for early disease detection and intervention
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ETIOME INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.